A Novel Role for CD46 in Wound Repair by John Cardone et al.
ORIGINAL RESEARCH ARTICLE
published: 07 July 2011
doi: 10.3389/ﬁmmu.2011.00028
A novel role for CD46 in wound repair
John Cardone, Samia Al-Shouli and Claudia Kemper*
MRC Centre for Transplantation, King’s College London, Guy’s Hospital, London, UK
Edited by:
Uday Kishore, Brunel University, UK
Reviewed by:
Uday Kishore, Brunel University, UK
Chenhui Zou, Brigham andWomen’s
Hospital, USA
*Correspondence:
Claudia Kemper, MRC Centre for
Transplantation, King’s College
London, Guy’s Hospital, 5th Floor,
TowerWing, Great Maze Pond,
London SE1 9RT, UK.
e-mail: claudia.kemper@kcl.ac.uk
The intestinal epithelium not only provides a vital physical barrier between the host and
environment but is also required for uptake of nutrients and the induction of tolerance
against commensals. Deregulation of any of these functions leads to several disease states
including chronic infection, inﬂammatory bowel disease, and cancer. Here, we describe a
novel role for the complement regulator CD46 in the regulation of intestinal epithelial cell
(IEC) barrier function. We found that CD46 directly interacts in IECs with the cytoplasmic
kinase SPAK and with transmembrane E-cadherin, both proteins necessary for epithelial
cell junction and barrier formation. Further, CD46 activation on Caco-2 cells induced rapid
and signiﬁcant decrease in transepithelial resistance with concomitant increase in paracel-
lular permeability. Importantly, though CD46 activation of IEC layers allowed for increased
transgression of pathogenic E. coli, it also increased epithelial cell proliferation and accel-
erated wound repair. These data suggest a previously unappreciated role for CD46 in the
maintenance of epithelial cell barrier integrity as well as barrier repair. However, this role
for CD46 as “gate keeper” of the epithelium could also provide reason as to why so many
pathogens bind to CD46 as such event would facilitate infection.
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INTRODUCTION
The surface covered by the epithelium of the human intestinal
mucosa is estimated to be 300m2. It represents the widest sur-
face of the body and deﬁnes the interface between the host and
the external environment (Lotz et al., 2007). Intestinal epithe-
lial cells (IECs) provide an innate barrier between the body and
the gut lumen containing commensal bacteria and “non-self”
food-derived antigens, while simultaneously allowing exchange of
nutrients, electrolytes, and water (Menard et al., 2010). Thus, IECs
are constantly exposed to harmless microorganisms and perform
a major task by remaining tolerant and avoiding an inﬂammatory
reaction to resident commensals while staying responsive toward
invading pathogens (Mueller and Macpherson, 2006).
Equally fundamental though to the ability of tolerance induc-
tion is the integrity and polarity of IECs aswell as its reconstitution
after injury to avoid local or systemic bacteria dissemination (San-
sonetti, 2004). The selective paracellular permeability across the
epithelial monolayer is restricted and modulated by several types
of intercellular junctions including tight junctions (TJ), adher-
ence junction (AJ), and desmosome-like junctions (DS; Menard
et al., 2010). TJs seal the paracellular space and help maintaining
IECs structural and functional polarity (Furuse et al., 1998). These
dynamic structures encircle epithelial cells at the apical end of lat-
eral membranes while AJ and DS bridge lateral surfaces between
cells. TJs are composed of members of the occludin and claudin
proteins families and selectively open and close in response to
incoming signals such as cytokines and growth or stress factors
(Sansonetti, 2004). The E-cadherin/catenin network constitutes
the major part of AJs and is vitally required for normal cell/cell
interactions and epithelial cell layer function (Vermeulen et al.,
1999; Van Aken et al., 2001; Kobielak and Fuchs, 2004; Yamada
et al., 2005). E-cadherin can form homotypic dimers linking adja-
cent epithelial cells thereby functioning as intercellular anchor. α-
E-catenin binds to the intracellular portion of E-cadherin thereby
connecting E-cadherin to the actin cytoskeleton and also transmit-
ting EGF/Wnt-mediated signals regulating protein degradation as
well as gene expression in epithelial cells (Yamada et al., 2005).
Deregulation or dysfunction of proteins involved in TJ and/or
AJ formation or function disrupt the normal epithelial barrier
integrity leading to activation of intestinal immunity and exposure
of internal tissues to commensal or pathogenic microorganisms
(Sansonetti, 2004). This can cumulate in chronic inﬂammation
and barrier dysfunction which is characteristic of inﬂammatory
bowel diseases (IBDs) such as Crohn’s disease and ulcerative coli-
tis (Hugot et al., 2001;Ogura et al., 2001). In addition,mutations in
E-cadherin, α-E-catenin, or occludins as well the deregulation of
their expressionproﬁles are implicated in various steps of intestinal
cancer development (Vermeulen et al., 1999; Kobielak and Fuchs,
2004).
CD46 is a ubiquitously expressed type I transmembrane gly-
coprotein and was initially discovered as a complement regula-
tory protein: CD46 binds the opsonins C3b and C4b, acts as a
cofactor in their factor I-mediated proteolytic degradation and
thereby inhibits unwanted complement deposition on host tissue
(Liszewski et al., 1991). Beside its role as a complement regulator,
CD46 is also involved in fertilization processes (Riley et al., 2002)
the regulation of Th1 cell responses (Astier et al., 2000; Kemper
et al., 2003; Sanchez et al., 2004; Kemper and Atkinson, 2007; Car-
done et al., 2010) and serves as a cell entry receptor for an increas-
ing number of major human pathogens (Cattaneo, 2004; Cardone
et al., 2010). CD46 is generally expressed in four isoforms that
arise from a single alternatively spliced gene (Kemper et al., 2005).
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All isoforms contain at the N-terminus four complement control
protein repeats (CCPs), followed by a differentially spliced highly
O-glycosylated region, a transmembrane anchor and then one of
two alternatively spliced intracellular tails, designated as CYT-1
and CYT-2 (Liszewski et al., 1991; Riley-Vargas et al., 2004). Both
of these intracellular domains contain several conserved phos-
phorylation and signaling motifs and CD46 induces intracellular
signaling events on several human cell types (Riley-Vargas et al.,
2004).
A number of studies suggest that CD46 also plays a role in
the polarization of human epithelium. In fact, the tail CYT-1 of
CD46 binds to the protein DLG4 in kidney epithelial cells and this
interaction is important for cell polarization (Ludford-Menting
et al., 2002). Also, the interaction of CD46 with Neisseria menin-
gitidis or N. gonorrhoeae (two of the CD46-binding pathogens)
plays an important role in colonization of several human epithelial
cells by this pathogen The CD46/Neisseria interaction leads to dif-
ferent epithelial cell modiﬁcations including: the transmission of
intracellular signals by CD46, rearrangement of the cytoskeleton,
calcium ﬂux, and ultimately bacterial uptake by the epithelial cell
(Kallstrom et al., 1998; Lee et al., 2002; Crimeen-Irwin et al., 2003;
Gill and Atkinson, 2004). Similarly, CD46 is required for inter-
nalization of opsonized uropathogenic Escherichia coli by human
kidney epithelial cells and a deﬁciency in CD46 leads to a decrease
in microbe internalization (Li et al., 2006). Lastly, mice transgenic
for human CD46 (rodents do not express CD46 on somatic tissue;
Inoue et al., 2003) show an increased transgression of N. menin-
gitides through the blood brain barrier compared to wild type
animals and are more susceptible to lethal meningococcal disease
(Johansson et al., 2005).
We have recently published on a novel interaction between
CD46 and the Ste20/SPS1-related serine/threonine kinase (SPAK)
in humanCD4+ Tcells identiﬁed by a yeast-two-hybrid screen.We
have shown that the CD46/SPAK interaction is required to switch
IFN-γ-producingTh1 cells from this pro-inﬂammatory into an IL-
10-secreting (self)regulative state (Cardone et al., 2010). However,
SPAK is better known for its function in osmotic stress regulation
(Li et al., 2004; Smith et al., 2008) as well as regulation of intesti-
nal barrier integrity (Yan et al., 2007, 2009). In fact mutations of
SPAK in humans are connected with reduced epithelial cell/cell
adhesion and onset of IBD (Yan et al., 2007). Further, we have now
also identiﬁed E-cadherin and α-E-catenin as potential binding
partners for the intracellular domain(s) of CD46 within the same
yeast-two-hybrid screen. These observations together prompted
us to investigate whether CD46-mediated signaling events com-
municate with the E-cadherin/catenin network or SPAK in IECs
and contribute to epithelial cell barrier integrity. Utilizing Caco-
2 in vitro trans-well and culture systems, we found that CD46
activation – surprisingly and counter-intuitively to the usually
immunoprotective function of complement – reduced transep-
ithelial resistance and increased paracellular permeability of IEC
monolayers.However, thoughCD46activation allowed thereby for
an increased transgression of pathogenic bacteria across the cell
layer, it also induced increased cell proliferation and accelerated
wound healing. These data suggest that CD46 plays a previously
unacknowledged role in the regulation of epithelial cell barrier
integrity and repair – andmayprovide an additional reason (beside
the observed negative regulation of Th1 cell immunity via CD46)
as to why pathogens chose CD46 as cell receptor.
MATERIALS AND METHODS
CELLS AND BACTERIA
The human intestinal cell line Caco-2 (clone HTB-37) was
obtained from ECACC (European Collection of Cell Cul-
tures, Health Protection Agency Culture Collection, Salisbury,
UK) and cultured according to the standard protocol in Dul-
becco’s modiﬁed Eagle’s medium (DMEM) supplemented with
10% heat-inactivated fetal calf serum, 1% non-essential amino
acids, 100U/ml penicillin, 100μg/ml streptomycin, and 2mM
l-Glutamine. Depending on the experimental set up, cells were
cultured in gelatin-coated 48-well plates (Iwaki, Asahi Glass Co.,
Ltd., Japan), 24 trans-well systems (polycarbonate membrane,
pore size 0.4μm,membrane insert∅ 12mm;Corning,USA) or in
wells provided by the CytoSelect™ 24-Well Wound Healing Assay
(Cell Biolabs Inc., USA) for 6–7 days minimum to a fully con-
ﬂuent monolayer. Epithelial cell layer integrity (i.e., formation of
functional TJs and AJs) was monitored by (transepithelial resis-
tance) TER measurement where applicable. The uropathogenic E.
coli strain J96 is a serum-resistant, hemolysin-secreting strain that
expresses type 1 and P ﬁmbriae and was obtained from ATCC
(clone 700336). J96 bacteria were grown in Luria–Bertani broth
(Sigma Aldrich, Saint Louis, USA) and bacteria numbers assessed
by photospectrometry at 600 nm.
ANTIBODIES AND REAGENTS
The monoclonal antibody clones TRA-2-10 (against SCR 1 of
CD46) and GB-24 (against SCRs 3 and 4) were a gift from
John Atkinson, (Washington University of Saint Louis, MO, USA;
Liszewski et al., 2000) and the monoclonal control antibody clone
MOPC-21 was purchased from BD Biosciences (San Jose, CA,
USA). TRA-2-10 and MOPC-21 were labeled with PE using the
Invitrogen Zenon® Mouse R-phycoerythrin Mouse IgG1 Label-
ing Kit (Invitrogen, Carlsbad, CA, USA). The rabbit polyclonal
anti-SPAK antibody was custom-generated by Invitrogen using a
peptide spanning aa 403–419 of SPAK for immunization (Car-
done et al., 2010) and antibodies raised against human E-cadherin
(FITC) and α-E-catenin as well as Annexin-APC were obtained
from BD Biosciences. Horseradish peroxidase (HRP)-conjugated
“secondary”antibodies for the detection of primaryAbs inwestern
blot analyses were from Amersham (Biosciences, Piscataway, NJ,
USA). The Staurosporine, propidium iodide, and FITC-labeled
dextran beads of 5 kDa size were bought from Sigma Aldrich.
CO-IMMUNOPRECIPITATION
Caco-2 cells were cultured for 7 days in gelatin-coated 24-well
plates. A mAb to CD46 (TRA-2-10) or an isotype control mAb
was added at 10μg/ml for 3 h. Cells were then lysed in lysis buffer
[1% v/v maltoside, 50mM Tris–HCl (pH 8.0), 150mM NaCl,
1mM EDTA, 1.5mM MgCl2, 10% glycerol], and protease and
phosphatase inhibitors (Sigma Aldrich). Lysates were incubated
with a mAb GB-24 (anti-CD46) or an isotype-matched control
mAb covalently coupled to Sepharose (Amersham) overnight at
4˚C. After washing, bound proteins were eluted, quantitated and
analyzed by Western blotting under reducing conditions.
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MEASUREMENT OF TRANSEPITHELIAL RESISTANCE AND
PARACELLULAR PERMEABILITY
To assess the effect of CD46 activation on epithelial cell barrier
integrity of Caco-2 cells, TER, and paracellular permeability were
measured in cell cultures before and after CD46 activation. TER:
Caco-2 cells were cultured in 24-well trans-well plates for up to
10 days and TER was measured daily using the EVOM2 (epithe-
lial voltohmmeter, World Precision Instruments Inc., Sarasota,
FL, USA) and STX2 “chopstick” electrodes as per manufacturer’s
protocol. When TER reached a minimum of 1000Ω/cm2, either
monoclonal antibodies (mAbs) to CD46, an isotype control mAb
(10μg/ml), or EtOH (ﬁnal concentration of 15%) was added to
the upper chamber andTERmeasured at different timepoints post
activation. Paracellular permeability : Caco-2 cells were cultured in
24-trans-wells until they reached a minimum TER of 1000Ω/cm2.
FITC-labeled dextran beads of a 5-kDA size (1mg/ml) or 107 J96
bacteria/ml that had been ﬂuorochrome-labeled utilizing the PKH
and CellVue® Claret Fluorescent Cell Linker Dyes (Sigma Aldrich,
Saint Louis, USA) were added to the upper chamber with or with-
out the addition of mAb toCD46, an isotype controlmAbor EtOH
(15% ﬁnal concentration). At different time points, aliquots of the
cell medium were collected from the upper and lower chamber.
Transgression rate of labeled dextran beads was determined by
measuring accumulated ﬂuorescence in these samples with a Flu-
orescenceOptimeter (FLUOstarOmega,BMGLabtech,Aylesbury,
UK) at 530 nm while transgression of bacteria was monitored
by ﬂow cytometric analysis of samples using a FACSCalibur™
(Becton Dickinson, Oxford, UK) and the VenturiOne program
(Applied Cytometry, Shefﬁeld, UK) for analysis.
CELL PROLIFERATION MEASUREMENT
Caco-2 cells were seeded into 24-well plates at varying starting
dilutions and cultured over night. mAbs to CD46, an isotype con-
trol mAb (10μg/ml) or staurosporine (200 μM) were then added
and cell proliferation rates were measured utilizing the CellTiter
96®AQueousOne SolutionCell ProliferationAssay fromPromega
(Madison, WI, USA) at different time points according to the
manufacturer’s protocol.
WOUND HEALING ASSAY
Caco-2 cells were cultured in 24-wells provided by the CytoS-
elect™ 24-Well Wound Healing Assay Kit. At day 7 of culture,
the linear spacer inserted in the well was removed, which created
a regular and deﬁned “wound” within the cell monolayer. Wells
were either left untreated or treated with 10μg/ml mAb to CD46
or an isotype control mAb (conditions were performed in tripli-
cate) and further cultured. Closure of wound areas was monitored
by time-laps microscopy [Canon EOS 50D (Canon UK Ltd., Sur-
rey)] anddigital pictureswere analyzedusingMetaMorph software
(Molecular Devices, Downingtown, PA, USA).
STATISTICAL ANALYSIS
Variables are represented as mean± SD. One-factor analysis of the
paired Student’s t -test [Excel software (Microsoft, Redmond, WA,
USA)] was used for data analyses and statistical signiﬁcance was
set at p< 0.005.
RESULTS
CD46 INTERACTS WITH OR MODULATES EXPRESSION OF PROTEINS
REQUIRED FOR MAINTENANCE OF EPITHELIAL CELL LAYER INTEGRITY
Although both of CD46’s intracellular domains CYT-1 and CYT-
2 can transmit intracellular signals in several cell types (Wang
et al., 2000; Riley-Vargas et al., 2004; Astier and Haﬂer, 2007),
the exact pathways translating into CD46’s biological functions
remain mostly unknown. Using a yeast-two-hybrid screen with a
Jurkat T cell library as a“bait” source, we have previously observed
that the Ste20/SPS1-related kinase (SPAK) interacts with CD46
CYT-1 and CYT-2 in primary human CD4+ T cells (Cardone
et al., 2010). SPAK is a broadly expressed serine/threonine kinase
with key roles in MAPK activation (Johnston et al., 2000; Delpire
and Gagnon, 2008). Though we observed that the SPAK/CD46
interaction is required for CD46-driven IL-10 production in
T cells (in line with a role for SPAK in T cell activation; Li
et al., 2004), SPAK was initially discovered as a stress-induced
key regulator of ion co-transporters (Delpire and Gagnon, 2008),
systemic ﬂuid homeostasis (San-Cristobal et al., 2009) and reg-
ulator of IEC layer integrity (Yan et al., 2007). In addition to
SPAK, we also identiﬁed α-E-catenin and the intracellular por-
tion of E-cadherin as CD46-interacting proteins in the same
yeast-two-hybrid screen. α-E-catenin and E-cadherin are key con-
stituents of the E-cadherin/catenin network forming the AJs that
are vitally required for normal cell/cell interactions and epithelial
cell layer maintenance (Vermeulen et al., 1999; Van Aken et al.,
2001; Kobielak and Fuchs, 2004; Yamada et al., 2005). The interac-
tion of CD46 with these proteins suggested to us that CD46 may
function in the regulation of IEC barrier regulation and we ﬁrst
assessed if CD46 indeed binds to SPAK,α-E-catenin,or E-cadherin
in the human epithelial colorectal adenocarcinoma cell line, Caco-
2. These cells express CD46 on the apical as well as basolateral
surfaces (Sinn et al., 2002; anddata not shown). Immunoprecipita-
tion conﬁrmed that SPAK constitutively bound to CD46 in Caco-2
cells, while the E-cadherin/CD46 interaction was only observed
when the cells were activated with mAbs to CD46 (Figures 1A,B).
In contrast, we have not been able to co-immunoprecipitate CD46
and α-E-catenin in Caco-2 cells under any activation conditions
tested (Figure 1B; of note, however, we can co-immunoprecipitate
CD46 and α-E-catenin in human CD4+ T cells, not shown). We
further observed that CD46 cross-linking increases E-cadherin
expression on Caco-2 cells (Figure 1C) but does not impact on
SPAK or α-E-catenin expression levels (data not shown). Success-
ful CD46 activation throughout these experiments was monitored
by CD46 downregulation (Figure 1D) – which is an acknowl-
edged consequence of CD46 stimulation observed on any cell type
analyzed so far (Riley-Vargas et al., 2004).
CD46-MEDIATED SIGNALS REGULATE INTESTINAL EPITHELIAL
BARRIER FUNCTION
In the previous set of data, we established a novel connection
between CD46 and proteins involved in the maintenance and reg-
ulation of the intestinal epithelium (Vermeulen et al., 1999; Van
Aken et al., 2001; Kobielak and Fuchs, 2004; Yamada et al., 2005;
Yan et al., 2007, 2009).We next assessed potential functional impli-
cations of this new link and determined whether CD46-induced
signals can modulate epithelial barrier integrity in Caco-2 cells
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FIGURE 1 | CD46 interacts with and/or modulates expression of
proteins required for intestinal epithelial cell layer integrity.
(A,B) CD46 associates with SPAK and E-cadherin in human colon
epithelial cells. Caco-2 cells were activated for 3 h by receptor
cross-linking using the antibodies indicated, and cell lysates used for
immunoprecipitation with a CD46-speciﬁc or isotype control mAb.
Immunoblotting with an anti-CD46 mAb assessed successful precipitation
while anti-SPAK, anti-α-E-catenin, and anti-E-cadherin antibodies revealed an
association between CD46 and SPAK and CD46 and E-cadherin. Untreated
lysates from non-activated cells were loaded as control (“lysate”). Data are
representative of three similarly performed experiments. (C) CD46 activation
increases E-cadherin expression in Caco-2 cells. Caco-2 cells were either left
non-activated or activated as described under (A) (but for 12 h) and E-cadherin
expression levels determined via FACS analysis. CD46 activation did not
modulate α-E-catenin or SPAK expression levels (data not shown). FACS plot
shown is representative of three separately but similarly performed
experiments. (D) CD46 activation of Caco-2 cells induces rapid CD46
downregulation. Caco-2 cells were activated as indicated and CD46
expression levels measured at 2, 4, and 24 h post activation. Data represent
mean±SD (n= 3). NA, non-activated.
cultured in a trans-well system. The formation of intercellular TJs
and AJs is a rate-limiting barrier, inhibiting paracellular ﬂow of
ions and larger solutes and resulting in measurable differences in
the ion concentration between the upper and lower chamber of
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the trans-well. These ion differences are measured and expressed
as TER. Caco-2 cells were cultured for up to 10 days and functional
barrier formation through TJ and AJ assembly monitored via
increasing TER (Figure 2A). mAbs to CD46 were added to Caco-2
cultures with a TER≥ 1000Ω/cm2. Within 30min post activation
TER decreased by 70% of the initial value while an isotype control
mAb showed only marginal TER decrease (Figure 2B). Ethanol
(EtOH), a cell toxin was added in concentrations above 5–10%,
FIGURE 2 | CD46 regulates epithelial cell barrier integrity in Caco-2 cell
monolayers. (A) Caco-2 cell monolayers form functional TJs and AJs. Caco-2
cells were seeded at 5× 104 cells/well in the upper well of a trans-well
system. TER, a measure of functional TJ and AJ formation) was assessed
every 2 days for a period of 10 days. Shown is theTER measured in four wells
over 10 days. Data are representative of three similarly performed
experiments. (B) CD46 activation decreasesTER. Caco-2 cells were cultured
in trans-wells until a minimum of 1000Ω/cm2 was reached. Either anti-CD46
mAb, an isotype control mAb or 15% ﬁnal concentration EtOH were added to
the upper well andTER measured at the indicated time points. Activation
conditions were performed in triplicate (data shown are mean value) and
shown is the result of one of three similarly performed experiments. (C)
CD46 activation increases paracellular permeability. Caco-2 cells were grown
and activated as described under (A) but with the addition of FITC-labeled
dextran beads (5 kDa size) into each upper chamber. At indicated time points,
sample aliquots were taken from the lower trans-well chambers and the
amount of transgressed beads measured. Shown is one representative of
three similarly performed experiments. (D) CD46 activation increases
transgression of uropathogenic bacteria. Experiments were performed as
under (C) but with the addition of J96 bacteria instead of dextran beads into
the upper chamber. Data shown are mean±SD of two similarly performed
experiments. (E) CD46 activation does not induce apoptosis or cell death.
Caco-2 cells were cultured in 24-wells for 6 days.Wells were either left
non-activated or treated with mAb to CD46, an isotype control mAb or
staurosporine, an apoptosis-inducing agent. Apoptosis was analyzed by
combined Annexin and propidium iodide staining at 4 and 24 h post activation.
Data shown are the mean±SD and representative of four experiments. NA,
non-activated; Stau, staurosporine; ns, statistically not signiﬁcant.
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to the cultures as a positive control and reduced TER to about
60% albeit with slower kinetics compared to CD46 activation
(Figure 1B). Reduction of TER was maintained in the presence
of CD46 activation for up to 36 h (Figure 1B). However, when
CD46-activating mAbs were removed after activation, TER was
fully restored within 2–3 days (data not shown), indicating that
CD46-mediated TER decrease is a reversible process.
The biological function of TER regulation includes epithelial
cell growth control (see below) and the controlled transport or
transgression of solutes and particles between the paracellular
space of epithelial cells via the “opening” of TJs and AJs. Evi-
dence underpinning that CD46 activation of Caco-2 cells indeed
regulates paracellular permeability was provided by our observa-
tion that the addition of CD46 cross-linking mAbs to cell cul-
tures increased the transgression of FITC-labeled 5 kDa dextran
beads from the upper to the lower trans-well chamber signiﬁ-
cantly (Figure 2C). Importantly, the kinetics of CD46-induced
bead transgression are fully in line with those observed for CD46-
mediated TER changes (Figure 2B). To assess CD46’s function in
epithelial cell barrier function toward amore physiological“agent,”
we next analyzed the transgression of the uropathogenic E. coli
strain J96 in the presence of CD46 activation (Figure 2D). Simi-
larly to the experiments using beads, E. coli bacteria accumulated
faster and inhigher numbers in the lower trans-well chamberwhen
CD46 activation tookplace. The high statistical deviation observed
when bacteria were used in the transgression experiments is likely
due to the more complex interaction of the microbes with the
epithelial cells (i.e., concurrent activationof toll-like receptors etc.)
compared to the usage of beads.
Importantly, the observed CD46-mediated increase in TER and
paracellular permeability in Caco-2 cell cultures are not due to
increased apoptosis or cell stress as neither the addition of mAbs
to CD46 nor the isotype control mAb increased Annexin V bind-
ing (or propidium iodine staining, data not shown; Figure 2E).
Thus, these data indicate that CD46 activation modulates TJ and
AD expression or function and by this decreases barrier function
of IECs.
CD46 ACTIVATION PROMOTES CELL GROWTH AND ACCELERATES
WOUND HEALING IN INTESTINAL EPITHELIAL CELLS
Proliferation of epithelial cells is controlled by contact inhibition.
In this process, the formation and constellation of TJ and AJ even-
tually induces growth stop while a decrease in TJ and/or AJ or
impairment of their integrity initiates cell proliferation (Zeng and
Hong, 2008).We therefore assessed if CD46-mediated modulation
of TJ andAJ formation impacts onCaco-2 cell proliferation. Caco-
2 cells were activated with either CD46 mAbs, an isotype-speciﬁc
control mAb or treated with staurosporine for 24 or 48 h and then
assessed for cell proliferation (Figure 3A). Whilst staurosporine
treatment induced, as expected, cell death, CD46-activated cells
showed a signiﬁcant increase in proliferation compared to the
control mAb-treated cultures.
We conﬁrmed the effect of CD46-mediated signals on epithelial
cell growth using a wound healing assay. Caco-2 cells were cul-
tured on 24-wells with a removable insert that created a deﬁned
“wound-like” area upon removal (Figure 3B, photographs). mAbs
to CD46 or an isotype control Ab was added and cell growth
monitored via time-lapse microscopy over 18 h. In agreement
with the data obtained in the proliferation assay (Figure 3A), we
observed that CD46 engagement accelerated would closure sig-
niﬁcantly compared to the addition of control mAb (Figure 3B,
lower graph).
In summary, we have shown here that CD46 interacts with
SPAK and E-cadherin, proteins important for normal epithelial
barrier function in IECs, and that CD46 activation decreases TER
FIGURE 3 | CD46 activation accelerates wound healing. (A) CD46
activation increases cell proliferation. Caco-2 cells were seeded into
24-wells at 1.5× 104 cells/well and allowed to adhere over night.Wells were
then left untreated or treated with 10μg/ml mAb to CD46, an isotype
control mAb or staurosporine (200μM) and cell proliferation measured 24
and 48 h post treatment. Data shown are the mean±SD and
representative of four experiments. (B) CD46 activation leads to
accelerated wound closure. Caco-2 cells were cultured on 24-wells with a
removable insert. After 6 days, the insert was removed and revealed a
deﬁned “wound-like” area (upper panels). mAbs to CD46 or an isotype
control Ab was added and cell growth monitored via time-lapse microscopy.
Lower panel shows the statistical analysis using MetMorph of the data
obtained visually. Data shown are the mean±SD and representative of
three experiments. ns, statistically not signiﬁcant.
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and increases paracellular permeability and by this promotes cell
growth and would healing in in vitro cultured Caco-2 cells.
DISCUSSION
The complement system has been viewed traditionally as a sen-
tinel system circulating in the blood and lymph with the rather
simple task to directly kill bacteria or opsonize and tag them for
uptake by phagocytes. From the early 1970s on, this view changed
as it became apparent that complement activation participates in
many processes of the adaptive immune arms as it is also required
for the optimal induction of B and T cells responses as well
as generation of lymphocyte memory pool (Ricklin et al., 2010;
Cope et al., 2011). A ﬂurry of recent studies now suggest an even
broader functional repertoire of this ancient system as it seems
that complement-mediated signaling events are equally necessary
for the timely shut down of Th1 responses in humans, and by this
for tolerance induction and immune homeostasis (Cardone et al.,
2011).
Our ﬁnding that the complement protein CD46 regulates IECs
barrier function would be fully in line with an expected guard-
ing role of the complement system at such vital host/environment
interface. In our experimental system, we have activated CD46
by mAbs. Natural non-pathogenic ligands for CD46 include
the opsonins C3b and C4b. The intestinal lumen contains high
amounts of C3 and C3b and several types of epithelial cells secrete
C3 (which is then converted to C3b) upon activation by cytokines,
tissue damage, or other stress signals (Moon et al., 1997). Thus,
CD46 activation at this location can easily be envisioned in an
in vivo setting.However, the observation that the addition of mAbs
to CD46 decreased epithelial barrier was unexpected – speciﬁcally
in the presence of pathogenic bacteria as one would content that
“sensing” of danger by a complement component would rather
increase barrier function to protect the host from infection. Our
data are in good agreement with the observation that mice trans-
genic for humanCD46 show increased transgressionof pathogenic
Neisseria through the blood brain barrier and subsequent high
infection and mortality rate (Johansson et al., 2005). In fact, mice
do not express CD46 on somatic cells (Inoue et al., 2003) and are
usually not susceptible to pathogens targeting CD46 as cell entry
receptor (Kemper et al., 2005).
The ﬁnding though that CD46 activation also increased cell
proliferation and wound healing suggests that CD46’s normal
functional role on IECs may rather be homeostatic via the induc-
tion of barrier repair after pathogen breach or other injury
(and that some pathogens plainly take advantage of this “house-
keeping” function). The induction of epithelial cell proliferation
and repair mechanism are induced via changes in TJ and AJ for-
mation and signaling events triggered by those changes. Although
the underlying mechanism is undeﬁned, a vital role for comple-
ment activation in the repair after liver injury has previously been
proposed as mice deﬁcient for C3 and/or C5 fail to initiate hepa-
tocyte proliferation and tissue repair in a liver injury model (He
et al., 2009). Accordingly, patients with liver cirrhosis and impair-
ment of tissue repair present with very low levels of circulating C3
and C4 (Nakamura et al., 1995). Interestingly, when we performed
similar experiments using a tubular kidney epithelial cell line, we
did not observe CD46-mediated changes in TER or proliferation,
despite successful CD46 activation assessed by CD46 downregu-
lation (data not shown). This may indicate that CD46’s regulates
epithelial barrier function at speciﬁc locations.
A better understanding of the exact mechanism(s) by which
CD46 regulates TJ and/or AJ formation or activation will now
require an assessment of the CD46-mediated signaling events post
activation in these cells. There are several possibilities as to how
CD46 could participate in barrier homeostasis. CD46-mediated
signals could impact (possibly via SPAK and/or α-E-catenin)
on the expression level of TJ and AJ proteins (Figure 4A). We
have indeed observed an increase in E-cadherin expression upon
CD46 activation and any changes in E-cadherin expression are
generally connected with AJ functional changes (Ayollo et al.,
2009). Interestingly, this has also been observed for changes in
α-E-catenin and SPAK levels or functions (Kobielak and Fuchs,
2004; Yan et al., 2009). Studies on CD46-mediated impact in
the expression of TJ proteins such as occludins and claudins
have so far not been performed but will likely unravel also a
cross-connection or-regulation axis as both TJs and AJs need to
FIGURE 4 | Possible mechanisms of CD46-mediated epithelial cell barrier
regulation. (A) Activation of CD46 expressed on the apical (or basal) surface
of epithelial cells leads to signaling via SPAK and/or α-E-catenin that regulates
E-cadherin (AJ formation) and possibly TJ formation. (B) CD46 is part of TJs
and its activation thereby directly impacts TJ formation and AJ function via the
CD46/E-cadherin interaction. (C) CD46-mediated signals may regulate the
Notch/Wnt pathways, which in turn impact on epithelial cell
layer integrity.
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undergo modiﬁcations for TER changes. We did attempt to knock
down protein expression of either CD46, SPAK, α-E-catenin or
E-cadherin via siRNA technique to assess which of those com-
ponents act downstream of CD46 in intercellular junction and
TER regulation (data not shown). However, and as it has been
published, we found that knockdown of either SPAK, E-cadherin,
or α-E-catenin impaired proper Caco-2 cell monolayer formation
and TER establishment (Yan et al., 2009). Interestingly, this was
also the case after CD46 knock down (data not shown). Thus,
these data clearly underscore the importance of these proteins
in intestinal barrier function but also make it difﬁcult to assess
their functional interrelationship. However, the observation that
CD46 knock down prevented TER establishment could suggest
that CD46 may actually be an integral part of intercellular junc-
tions themselves (Figure 4B). Indeed, this has been proposed
previously in a study by Strauss et al. (2009) in which the authors
showed that CD46 is located within the TJs of ovarian cancer
cell lines and that adenovirus targeted CD46 during epithelial-
to-mesenchymal transition. Additionally, members of the DLG
protein family have been implicated in TJ formation (Ivanov et al.,
2010) and one of them, DLG4 has been shown to bind CD46 in
kidney epithelial cells (Ludford-Menting et al., 2002).
As an interesting third option (and these models may not be
mutually exclusive),we suggest a potential crosstalk betweenCD46
and the Notch and/or Wnt system in IECs (Figure 4C). This idea
is based on our recent observation that CD46 regulates the expres-
sion of Notch 1 and 2 as well as their ligands jagged-1 and delta-1
in human CD4+ T cells (Le Friec et al., 2010; Cope et al., 2011).
The Notch system is vitally important for homeostasis of IECs and
transmits intracellular signals via the α- and β-catenin pathways
(Peignon et al., 2011). Given these commonalities, it is feasible to
suggest also a functional relationship between complement/CD46
and the Notch system in the gut epithelium.
A role for CD46 in the regulation of barrier function and
growth could have major implications for several disease states.
For example, disturbance in CD46-mediated TJ and AJ function
(via mutations in CD46 leading to suboptimal or excessive signal-
ing) could induce“leakage”of the gut ﬂora from the lumen into the
surrounding tissue and may cumulate into chronic inﬂammation
such as observed in IBD (Hugot et al., 2001). This “phenotype”
may be further potentiated by an impairment of CD46-mediated
tissue/barrier repair. On the other hand, increased or uncon-
trolled induction of CD46-mediated cell proliferation may induce
malignant transformation of epithelial cells and adenocarcinoma
formation. Indeed,amutation inCD46 that retains protein expres-
sion on the cell membrane as well as CD46’s complement regula-
tory and ligand binding function but induces a nonsense mutation
in the intracellular domains has been identiﬁed in a colon cancer
patient (Sjoblom et al., 2006). In addition, DLG4 functions in
drosophila as a tumor suppressor, and the CD46/DLG4 interac-
tion may possibly serve in a similar pathway (Ludford-Menting
et al., 2002).
Thus,delineatingCD46’s function in healthy epitheliumhome-
ostasis may provide an opening to further understand the impact
of innate immune signals or their deregulation in chronic inﬂam-
mation and/or malignant transformation.
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